But this week, the stock jumped again after Amgen issued a strong financial update Tuesday. Its rise helped push up the S&P ...

What Happened? Shares of biotech company Amgen (NASDAQ:AMGN) jumped 5.3% in the morning session after the company reported ...

New prices aim to save billions by 2027. Vandana Singh FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation Amgen's Lumakras treatment, combined with Vectibix ...

Shares of Amgen (AMGN) fell in after-hours trading after the biotechnology company reported earnings for its fourth quarter ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Amgen Inc. closed 18.42% short of its 52-week high of $346.85, which the company achieved on July 25th.